Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Luis Ortiz

Sleep Medicine St Petersburg, FL Medical Doctor

NPI 1982921086 CMS profile 1400701

601 5Th St S, St Petersburg, FL 33701

Open in the dashboard

General payments

$23,629

43 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Luis Ortiz of St Petersburg, FL is reported in the CMS Open Payments database as having received $23,629 across 43 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Sleep Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $7,724 14
2024 General $5,284 12
2023 General $10,042 13
2022 General $16 1
2020 General $431 1
2019 General $132 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Luis Ortiz
  • Sleep Medicine median
  • Middle half of Sleep Medicine
  • National median

In program year 2025, general payments to Luis Ortiz were reported at $7,724. Among 68 Sleep Medicine profiles paid that year, the median was $243 and the middle half received between $103 and $631.

Show as a table
Year Luis Ortiz Sleep Medicine median Middle half National median
2019 $132 $107 $41–$185 $163
2020 $431 $102 $41–$216 $114
2021 $0 $85 $30–$159 $132
2022 $16 $163 $56–$485 $149
2023 $10,042 $151 $62–$443 $160
2024 $5,284 $173 $69–$444 $164
2025 $7,724 $243 $103–$631 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Jazz Pharmaceuticals Inc. $9,775 11 payments
  2. Avadel CNS Pharmaceuticals, LLC $7,394 18 payments
  3. Harmony Biosciences LLC $6,028 8 payments
  4. Inspire Medical Systems, Inc. $284 3 payments
  5. Avadel Specialty Pharmaceuticals, LLC $112 1 payment
  6. Shire North American Group Inc $20 1 payment
  7. Takeda Pharmaceuticals U.S.A., Inc. $16 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $21,398 21 payments
  2. Food and Beverage $1,460 19 payments
  3. Travel and Lodging $771 3 payments
Products named General payments · program years 2019–2025
  1. XYWAV $9,775 11 payments
  2. LUMRYZ $7,214 16 payments
  3. WAKIX Narcoplepsy $3,593 4 payments
  4. WAKIX Narcolepsy $2,435 4 payments
  5. INSPIRE $284 3 payments
  6. Noctiva $112 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

43 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sleep Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record